VKTX
#1537
Viking Therapeutics, Inc. - Common Stock
32.5 7 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.81%
Variación mensual
-3.78%
Variación en los últimos 6 meses
-1.24%
Cambio anual
+17.75%
Cierres anteriores
33.8 6
Open
33.0 0
Mínimo
32.5 5
Máximo
33.0 7
Volumen
464
Financials
- Market Capitalization 3.8 B
- Employee 59
- Founded 2012
- CEO Brian Lian
- Website www.vikingtherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG006LGV869
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1521 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 40.61 USD | -2.78% | +0.84% | +12.46% | +24.65% | 3.92 B USD | ||
| 1533 |  DNLI Denali Therapeutics Inc. - Common Stock | 24.03 USD | -2.59% | -3.49% | +0.63% | +48.61% | 3.84 B USD | ||
| 1551 |  TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.36 USD | -0.18% | +0.18% | +10.51% | +80.03% | 3.85 B USD | ||
| 1555 |  RCUS Arcus Biosciences, Inc. Common Stock | 29.44 USD | -3.79% | -3.03% | +7.09% | +175.91% | 3.75 B USD |